Edoxaban Tosylate API (CAS 480449-71-6)

Edoxaban Tosylate stands out as a critical component in modern cardiovascular medicine. Pharmaceutical manufacturers prioritize high-quality edoxaban tosylate api 480449-71-6 for the production of effective oral anticoagulants. This specific active pharmaceutical ingredient (API) serves as the potent salt form of Edoxaban. It acts primarily as a direct Factor Xa inhibitor. Doctors prescribe the final drug product to reduce stroke risk and treat venous thromboembolism. We will explore the technical details and manufacturing standards of this necessary raw material.

What Defines edoxaban tosylate api 480449-71-6?

Pharmaceutical companies seek specific chemical properties in their raw materials. Edoxaban Tosylate (CAS 480449-71-6) represents the tosylate monohydrate salt of Edoxaban. The salt form improves the bioavailability of the drug within the human body. Scientists engineered this molecule to target specific enzymes in the blood coagulation cascade.

The demand for reliable anticoagulant api options continues to grow. Edoxaban competes effectively with other Non-Vitamin K Antagonist Oral Anticoagulants (NOACs). Manufacturers produce this API as a white to pale yellowish powder. It demonstrates specific solubility characteristics necessary for tablet formulation.

Technical Specifications and Chemical Properties

Buyers must verify rigorous quality standards when they purchase edoxaban tosylate. We have compiled a detailed table of specifications below. These data points ensure the material meets global pharmacopeia standards.

Note: Manufacturers should check specific Certificates of Analysis (CoA) for batch-specific data.

Mechanism of Action for Factor Xa Inhibitors

Edoxaban functions through a highly specific biological mechanism. It belongs to the class of drugs known as direct Factor Xa inhibitors. Factor Xa plays a central role in the blood coagulation cascade. This enzyme converts prothrombin into thrombin. Thrombin subsequently converts fibrinogen into fibrin. Fibrin strands form the structural mesh of a blood clot.

Anticoagulant api molecules like Edoxaban disrupt this process directly. The molecule binds selectively to the active site of Factor Xa. This binding occurs reversibly. The inhibition prevents the generation of thrombin. Consequently, the blood loses its ability to form dangerous clots efficiently. The mechanism works without the need for a cofactor like antithrombin III. This direct action provides a predictable anticoagulant effect. Doctors appreciate this predictability because it simplifies patient monitoring.

Analyzing the edoxaban synthesis process

The manufacturing of this API involves complex organic chemistry. The edoxaban synthesis process requires multiple steps to build the molecular structure. Chemists typically start with key intermediates to construct the core skeleton.

Step 1: Intermediate Formation
The synthesis often begins with the reaction of a specific diamine with an acid derivative. This step forms the amide bond. Chemists must control the temperature strictly during this phase.

Step 2: Coupling Reaction
The next phase involves coupling the core structure with a thiazole moiety. This step introduces the sulfur and nitrogen heterocyles into the molecule. The reagents used here determine the yield and purity.

Step 3: Salt Formation
The final chemical step converts the Edoxaban free base into Edoxaban Tosylate. Chemists add p-toluenesulfonic acid (tosylic acid) to the solution. The mixture undergoes crystallization. This process yields the stable edoxaban tosylate api 480449-71-6.

Step 4: Purification
The crude crystals require purification. Manufacturers use recrystallization techniques to remove impurities. High-Performance Liquid Chromatography (HPLC) verifies the final purity. The result is a pharmaceutical-grade edoxaban tosylate raw material ready for formulation.

Quality Control for edoxaban tosylate api 480449-71-6

Quality assurance remains paramount in pharmaceutical manufacturing. Regulatory bodies like the FDA and EMA enforce strict guidelines. Suppliers must adhere to Good Manufacturing Practices (GMP).

Impurity Profiling
Manufacturers must identify and limit potential impurities. These impurities might arise from unreacted starting materials or side reactions. The International Council for Harmonisation (ICH) guidelines dictate the acceptable limits.

Stability Studies
The API must remain stable under various conditions. Stress testing evaluates the material against heat, humidity, and light. Edoxaban Tosylate shows sensitivity to moisture. Therefore, proper packaging is important. Suppliers typically use double polyethylene bags inside fiber drums.

Solvent Residues
The synthesis process uses various organic solvents. The final product must not contain dangerous levels of these solvents. Gas chromatography testing confirms that residual solvents fall within safe limits.

Clinical Applications and Therapeutic Uses

The pharmaceutical industry processes this API into oral tablets. These tablets serve millions of patients worldwide. The clinical efficacy of Edoxaban covers several cardiovascular conditions.

Stroke Prevention
Physicians prescribe Edoxaban primarily for patients with non-valvular atrial fibrillation (NVAF). These patients face a high risk of stroke due to blood clots forming in the heart. Edoxaban significantly lowers this risk.

Treatment of VTE
The API is effective as a deep vein thrombosis api. DVT involves clots forming in the deep veins of the legs. These clots can travel to the lungs. This condition is called pulmonary embolism (PE). Edoxaban treats both DVT and PE effectively. It also prevents the recurrence of these events.

Dosage Considerations
Formulators typically create tablets in strengths of 15mg, 30mg, and 60mg. The oral bioavailability allows for once-daily dosing. This convenient dosing schedule improves patient compliance significantly.

Handling and Storage Requirements

Warehouse managers must handle this chemical with care. Edoxaban Tosylate counts as a potent bioactive substance. Workers should wear appropriate personal protective equipment (PPE). This includes gloves, masks, and lab coats.

Storage Conditions
You should store the material in a cool, dry place. The temperature should remain between 2°C and 8°C for long-term stability. The container must remain tightly closed. Exposure to moisture can degrade the crystal structure.

Safety Precautions
Inhalation of the powder can cause systemic effects. Safety protocols prohibit eating or drinking in handling areas. In case of contact with skin, wash the area immediately with soap and water.

Selecting Reliable Suppliers

Pharmaceutical companies must vet their suppliers carefully. A reliable supplier provides complete documentation. This includes the Drug Master File (DMF) and Letters of Access (LoA).

Audit and Compliance
Buyers should conduct audits of the manufacturing facility. The facility must demonstrate full GMP compliance. The presence of a robust quality management system ensures consistent product quality.

Supply Chain Security
Dependable sourcing prevents production delays. Manufacturers should maintain relationships with multiple suppliers. This strategy mitigates risks associated with raw material shortages.

Specifically, when sourcing edoxaban tosylate api 480449-71-6. Different synthetic routes produce different impurities. A consistent impurity profile indicates a robust manufacturing process.

Frequently Asked Questions

What distinguishes Edoxaban from Edoxaban Tosylate?
Edoxaban is the active drug base. Edoxaban Tosylate is the salt form. Manufacturers use the salt form because it dissolves better in the body.

Is Edoxaban a steroid?
No, Edoxaban is not a steroid. It is a Non-Vitamin K Antagonist Oral Anticoagulant (NOAC).

What are the storage requirements for CAS 480449-71-6?
You must store it in a desiccated environment. Keep the temperature between 2°C and 8°C. Protect the container from light.

Does Edoxaban cure Deep Vein Thrombosis?
Edoxaban treats DVT by preventing the clot from growing. It allows the body to break down the clot naturally over time. It also prevents new clots from forming.